No registrations found.
ID
Source
Brief title
Health condition
haemophilia, Home treatment, prophylaxis, intravenous infusion, learningprocess.
Sponsors and support
Heidelberglaan 100, PO box 85500
3508 GA Utrecht, the Netherlands
Baxter Healthcare Corporation; unrestricted grant.
One Baxter Parkway
Deerfield, IL 60015-4625, United States
Intervention
Outcome measures
Primary outcome
Quantification of the learning process of self infusion and the self infusion procedure, that will serve as a base-line for futher research to improve adherence.
Secondary outcome
1. Time needed to learn to administer prophylaxis;
2. Timing of self infusion;
3. Proportion of infusions taken in the mornings in comparison with the bleeding frequency;
4. Age at which transition takes place.
Background summary
The primary objective of this retro/prospective observational study, is to quantify the process of Home treatment for haemophilia patients. The datacollection is combined with the regular nursing consultation.
Study objective
The primary objective is to quantify the learning process of self infusion and the self infusion procedure.
Study design
Data collection:
1. For research on self infusion: 3 years;
2. Retrospective data: 0.3 years.
Data Analysis: 0.5 years;
Report: 0.5 years.
Intervention
This study comprises a retro- and prospective observational study which is combined with a nursing consultation. The present project will expand the regular nursing consultation with a history, timing of infusion and an introduction of home-visits to patients who are using home-treatment since more than 1 year.
L.H. Schrijvers
University Medical Center Utrecht
Van Creveldkliniek/ Department of Hematology
Utrecht 3508 GA
The Netherlands
+31 (0)88 7551709
L.H.schrijvers-3@umcutrecht.nl
L.H. Schrijvers
University Medical Center Utrecht
Van Creveldkliniek/ Department of Hematology
Utrecht 3508 GA
The Netherlands
+31 (0)88 7551709
L.H.schrijvers-3@umcutrecht.nl
Inclusion criteria
1. All haemophilia or Von Willebrand type III patients or caretakers of children (with or without CVAD) treated with prophylaxis (possible learning for self infusion);
2. Patients who are treated at the van Creveldkliniek Utrecht, Haemophilia Treatment Centre Amsterdam, or Erasmus Medical Centre Rotterdam, in the estimated period from of 3 years.
Exclusion criteria
Patients who are treated on demand.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2295 |
| NTR-old | NTR2686 |
| Other | METC UMCU : 10-269/ C |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |